|
"The biotechnology industry is growing
up, and with maturity comes pain as well as discovery. Next year, an unprecedented
number of biotech drugs are poised to hit the market, and Ernst & Young analysts
expect the sector's revenue to rise by more than the average 11 % per year posted
since 1995." From Bionews, January 2, 2002.
When
those drugs hit the market, O'Brien and Roof plans on being there. At
O'Brien and Roof we are committed to being a part of the biotechnology revolution.
It is a very exciting time for the industry as a whole. Our areas of focus within
biotechnology are….
- Biotechnology Sales
- Pharmaceutical
Sales
- Life Science Research
Being
an innovator in biotechnology is all about diversity. Our client list shows just
this. Our clients range from Fortune 200 pharmaceutical companies to research
institutions to companies that specialize in biotechnology related database creation. "With
the future of health care, agriculture and industrial processes gravitating toward
biotechnology, many states are trying to position biotech as a catalyst for their
economies. Ohio is no different." Christopher Johnston from "The State
of Biotech" in Ohio Business June 2, 2001 O'Brien
and Roof has a high interest in partnering with companies that are committed to
bringing biotechnology to Ohio. In regards to federal grant money, Ohio is one
of the top ten most funded states. However, we are not in the top ten for new
biotechnology expansion. Our company is expecting that we will play a major role
in changing this.
Biotechnology Links
Important Biotechnology
Links
If you are are interested in learning
more about our services, please email monica@obrienroof.com.
| 
